V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10002353 | 10001543 | 1.87 | null | Neo-adjuvant (N) | 2014-01-23 | 2014-02-10 | CARBOPLATIN + VINORELBINE | N | N | 10432038 | CARBOPLATIN + VINORELBINE |
| 10002354 | 10001544 | 1.67 | 69.9 | Curative (C) | 2015-11-19 | 2015-12-17 | Rituximab | N | N | 10432063 | RITUXIMAB |
| 10002355 | 10006180 | null | 74 | Palliative (P) | 2018-01-26 | 2018-01-26 | Rituximab | N | N | 10432103 | RITUXIMAB |
| 10002356 | 10001545 | 1.68 | 75.8 | Palliative (P) | 2017-11-15 | 2017-11-20 | ECX | N | N | 10432107 | ECX |
| 10002357 | 10001546 | 1.68 | 71 | Palliative (P) | 2017-02-15 | 2017-02-15 | GEMCITABINE | 02 | N | 10432164 | GEMCITABINE |
| 10002358 | 10001547 | null | null | Palliative (P) | 2018-01-13 | 2018-01-13 | Hydroxycarbamide | N | null | 10432300 | HYDROXYCARBAMIDE |
| 10002359 | 10001548 | 1.63 | null | Palliative (P) | 2016-10-11 | 2016-11-02 | EOX | 02 | N | 10432316 | EOX |
| 10002360 | 10001549 | 0 | 64.1 | Curative (C) | 2017-02-25 | 2017-03-21 | CVP R | 2 | N | 10432338 | CVP R |
| 10002361 | 10001550 | 1.82 | 59.1 | Palliative (P) | 2017-08-23 | 2017-08-27 | Hydroxycarbamide | 02 | N | 10432349 | HYDROXYCARBAMIDE |
| 10002362 | 10001551 | 1.7 | 55 | Palliative (P) | 2017-05-03 | 2017-05-17 | Gemcitabine weekly | null | N | 10432353 | GEMCITABINE |
| 10002363 | 10001552 | 1.82 | 57.3 | Curative (C) | 2018-03-17 | 2018-03-20 | CVP R | 02 | N | 10432402 | CVP R |
| 10002364 | 10001552 | 1.56 | 71.2 | Disease modification (D) | 2018-02-11 | 2018-02-23 | R GCVP | N | N | 10432402 | CVP R |
| 10002365 | 10001552 | 1.75 | 88.7 | Disease modification (D) | 2017-02-24 | 2017-02-24 | Hydroxycarbamide | 02 | N | 10432402 | HYDROXYCARBAMIDE |
| 10002366 | 10001553 | null | 59.7 | Palliative (P) | 2016-02-02 | 2016-02-03 | Enzalutamide | N | N | 10432424 | ENZALUTAMIDE |
| 10002367 | 10001554 | 1.76 | 64.6 | Curative (C) | 2019-01-23 | 2019-01-24 | Hydroxycarbamide | 02 | N | 10432448 | HYDROXYCARBAMIDE |
| 10002368 | 10001555 | null | null | Palliative (P) | 2017-08-15 | 2017-08-18 | Cisplatin + Pemetrexed | N | null | 10432491 | CISPLATIN + PEMETREXED |
| 10002369 | 10001556 | 0 | 71 | Curative (C) | 2016-02-25 | 2016-03-06 | CISPLATIN + VINORELBINE | 2 | N | 10432513 | CISPLATIN + VINORELBINE |
| 10002370 | 10001557 | 1.72 | 77.7 | Neo-adjuvant (N) | 2017-09-19 | 2017-09-19 | ECX | 2 | N | 10432600 | ECX |
| 10002371 | 10001558 | 1.61 | 85.9 | Adjuvant (A) | 2017-09-08 | 2017-10-14 | Trial Unspecified | 1 | N | 10432605 | TRIAL |
| 10002372 | 10001559 | 1.59 | 83 | Palliative (P) | 2014-04-19 | 2014-05-10 | EOX | N | null | 10432619 | EOX |
| 10002373 | 10001559 | 1.7 | 0 | Palliative (P) | 2018-09-30 | 2018-10-27 | Gemcitabine weekly | N | N | 10432619 | GEMCITABINE |
| 10002374 | 10001560 | 1.7 | null | Palliative (P) | 2016-07-25 | 2016-08-07 | CARBOPLATIN + VINORELBINE | N | null | 10432697 | CARBOPLATIN + VINORELBINE |
| 10002375 | 10001561 | 1.53 | 52 | Disease modification (D) | 2016-04-21 | 2016-05-22 | Carboplatin + Vinorelbine Oral | 2 | N | 10432722 | CARBOPLATIN + VINORELBINE |
| 10002376 | 10001561 | 1.78 | 92 | Palliative (P) | 2016-05-13 | 2016-05-23 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 10432722 | GEMCITABINE |
| 10002377 | 10001562 | 1.53 | 83 | Palliative (P) | 2018-09-06 | 2018-09-20 | PEMBROLIZUMAB | 02 | N | 10432836 | PEMBROLIZUMAB |
| 10002378 | 10001563 | 1.73 | 65.2 | Disease modification (D) | 2019-03-11 | 2019-03-12 | Rituximab | 02 | N | 10432941 | RITUXIMAB |
| 10002379 | 10001564 | 1.74 | 88.6 | Neo-adjuvant (N) | 2015-07-11 | 2015-07-11 | ECX | N | N | 10432990 | ECX |
| 10002380 | 10001565 | 1.55 | null | null | 2017-06-23 | 2017-06-23 | Trial Unspecified | Y | N | 10433070 | TRIAL |
| 10002381 | 10001566 | 0 | 68.8 | Palliative (P) | 2019-05-18 | 2019-05-18 | Enzalutamide | N | N | 10433072 | ENZALUTAMIDE |
| 10002382 | 10001567 | 1.78 | null | Adjuvant (A) | 2013-12-28 | 2014-01-15 | CARBOPLATIN + VINORELBINE | 2 | N | 10433117 | CARBOPLATIN + VINORELBINE |
| 10002383 | 10001568 | 1.69 | 73 | Palliative (P) | 2015-10-13 | 2015-10-27 | Enzalutamide | N | N | 10433148 | ENZALUTAMIDE |
| 10002384 | 10001568 | 1.73 | 60.4 | Curative (C) | 2017-06-20 | 2017-06-28 | CVP R | 02 | N | 10433148 | CVP R |
| 10002385 | 10001568 | 1.67 | 64.8 | Palliative (P) | 2017-04-22 | 2017-04-22 | GEMCITABINE | N | N | 10433148 | GEMCITABINE |
| 10002386 | 10001568 | 1.76 | null | Palliative (P) | 2015-07-20 | 2015-07-20 | Enzalutamide | N | N | 10433148 | ENZALUTAMIDE |
| 10002387 | 10006185 | 1.78 | 95.8 | Disease modification (D) | 2017-09-13 | 2017-09-14 | PEMBROLIZUMAB | 01 | N | 10433234 | PEMBROLIZUMAB |
| 10002388 | 10001569 | null | 71.3 | Disease modification (D) | 2018-03-12 | 2018-03-15 | Rituximab | N | N | 10433281 | RITUXIMAB |
| 10002389 | 10001570 | 1.55 | 124 | Adjuvant (A) | 2017-05-17 | 2017-05-24 | Carboplatin + Vinorelbine Oral | N | N | 10433315 | CARBOPLATIN + VINORELBINE |
| 10002390 | 10001571 | 1.59 | 78 | Disease modification (D) | 2014-11-09 | 2014-11-09 | Hydroxycarbamide | 2 | N | 10433316 | HYDROXYCARBAMIDE |
| 10002391 | 10001572 | 1.82 | 62.4 | Curative (C) | 2016-06-05 | 2016-06-05 | Hydroxycarbamide | 02 | N | 10433345 | HYDROXYCARBAMIDE |
| 10002392 | 10001573 | 1.78 | 86.8 | Curative (C) | 2018-10-14 | 2018-10-17 | Hydroxycarbamide | N | N | 10433351 | HYDROXYCARBAMIDE |
| 10002393 | 10001574 | 0 | 72.4 | Palliative (P) | 2018-10-16 | 2018-10-21 | PEMBROLIZUMAB | 2 | N | 10433377 | PEMBROLIZUMAB |
| 10002394 | 10006186 | 1.76 | 62.2 | Palliative (P) | 2015-05-01 | 2015-05-16 | Cisplatin + Pemetrexed | 02 | N | 10433417 | CISPLATIN + PEMETREXED |
| 10002395 | 10007975 | 1.65 | 67 | null | 2018-10-17 | 2018-10-17 | Hydroxycarbamide | 2 | N | 10433454 | HYDROXYCARBAMIDE |
| 10002396 | 10001575 | null | 91.85 | Palliative (P) | 2015-07-09 | 2015-07-09 | PEMBROLIZUMAB | N | N | 10433493 | PEMBROLIZUMAB |
| 10002397 | 10001576 | 1.75 | 90 | Disease modification (D) | 2017-06-26 | 2017-06-26 | Hydroxycarbamide | N | N | 10433496 | HYDROXYCARBAMIDE |
| 10002398 | 10001576 | 1.6 | 46 | Disease modification (D) | 2017-10-28 | 2017-11-14 | Gemcitabine weekly | 2 | null | 10433496 | GEMCITABINE |
| 10002399 | 10001577 | 1.84 | 0 | Disease modification (D) | 2014-07-16 | 2014-07-17 | Hydroxycarbamide | 02 | N | 10433535 | HYDROXYCARBAMIDE |
| 10002400 | 10001578 | 1.8 | null | Palliative (P) | 2018-02-02 | 2018-02-02 | GEMCITABINE | 02 | N | 10433540 | GEMCITABINE |
| 10002401 | 10001578 | 1.75 | 85 | Disease modification (D) | 2017-02-18 | 2017-02-18 | Hydroxycarbamide | 02 | N | 10433540 | HYDROXYCARBAMIDE |
| 10002402 | 10007976 | null | 92 | Curative (C) | 2017-07-24 | 2017-07-25 | Hydroxycarbamide | N | N | 10433604 | HYDROXYCARBAMIDE |